The UK Health System's Response to the Monkeypox Outbreak of 2022: A Scoping Review.
- 1Department of Adult Social Care, Harrow Council, London, UK.
- 2Department of Health Promotion and Behavioral Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA.
- 3Department of Epidemiology and Population Health, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA.
Abstract
Introduction
The 2022 mpox outbreak represented a major shift in transmission dynamics, with sustained community spread occurring in several nonendemic countries, including the United Kingdom. Examining how nonendemic health systems responded to this outbreak is essential for strengthening preparedness for future emerging and re-emerging infectious diseases.Methods
A scoping review was conducted in accordance with the Preferred Reporting Items for Systematic and Meta-Analysis Extension for Scoping Reviews guidelines to synthesize evidence on the UK healthcare system's response to the 2022 mpox outbreak. Electronic databases and gray literature sources were searched for publications released between January and December 2022.Results
Evidence was mapped across seven World Health Organization-aligned intervention domains relevant to outbreak preparedness and response. Eleven sources were included, comprising peer-reviewed studies and policy-relevant gray literature. Evidence was most frequently reported for infection prevention and control (n = 7), systems for identifying emerging and re-emerging infections (n = 6), and rapid data sharing and risk communication (n = 5). Moderate evidence addressed community engagement (n = 5) and vaccine and therapeutic capacity (n = 5). In contrast, only one source examined laboratory systems (n = 1), and no studies described structured surge capacity training for healthcare workers.Conclusion
The UK response to the 2022 mpox outbreak demonstrated timely coordination, effective surveillance, and implementation of infection prevention measures in a nonendemic setting. However, important limitations remain, particularly in workforce surge capacity, domestic vaccine manufacturing, and evidence on postexposure vaccination effectiveness. Addressing these gaps is essential for strengthening health system resilience and preparedness for future outbreaks.
Related
- Governance, coordination, and accountability in public health emergency preparedness and response: A scoping review
- Quantifying nature exposure for the dose-response of green space and mental health: a scoping review
- Artificial intelligence and machine learning for organizational and system-level functions in primary health care: A scoping review protocol
- Civil-military coordination in health emergencies: Lessons for health system resilience from a Rift Valley fever response in Mali
- Pathways to health resilience: A cross-country analysis of health system response to re-emerging infectious diseases in Sub-Saharan Africa
BibTeX
@article{khan2026health,
title = {{The UK Health System's Response to the Monkeypox Outbreak of 2022: A Scoping Review.}},
author = {Harris Khan and Samir Kumar Sarker Rony and Venetia Aranha},
journal = {Journal of global infectious diseases},
year = {2026},
month = jul,
doi = {10.4103/jgid.jgid_215_25},
url = {https://europepmc.org/article/MED/42899014},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - The UK Health System's Response to the Monkeypox Outbreak of 2022: A Scoping Review.
AU - Harris Khan
AU - Samir Kumar Sarker Rony
AU - Venetia Aranha
PY - 2026
DA - 2026/07/01
JO - Journal of global infectious diseases
DO - 10.4103/jgid.jgid_215_25
UR - https://europepmc.org/article/MED/42899014
AB - Introduction The 2022 mpox outbreak represented a major shift in transmission dynamics, with sustained community spread occurring in several nonendemic countries, including the United Kingdom. Examining how nonendemic health systems responded to this outbreak is essential for strengthening preparedness for future emerging and re-emerging infectious diseases.Methods A scoping review was conducted in accordance with the Preferred Reporting Items for Systematic and Meta-Analysis Extension for Scoping Reviews guidelines to synthesize evidence on the UK healthcare system's response to the 2022 mpox outbreak. Electronic databases and gray literature sources were searched for publications released between January and December 2022.Results Evidence was mapped across seven World Health Organization-aligned intervention domains relevant to outbreak preparedness and response. Eleven sources were included, comprising peer-reviewed studies and policy-relevant gray literature. Evidence was most frequently reported for infection prevention and control (n = 7), systems for identifying emerging and re-emerging infections (n = 6), and rapid data sharing and risk communication (n = 5). Moderate evidence addressed community engagement (n = 5) and vaccine and therapeutic capacity (n = 5). In contrast, only one source examined laboratory systems (n = 1), and no studies described structured surge capacity training for healthcare workers.Conclusion The UK response to the 2022 mpox outbreak demonstrated timely coordination, effective surveillance, and implementation of infection prevention measures in a nonendemic setting. However, important limitations remain, particularly in workforce surge capacity, domestic vaccine manufacturing, and evidence on postexposure vaccination effectiveness. Addressing these gaps is essential for strengthening health system resilience and preparedness for future outbreaks.
SN - 0974-777X
SN - 0974-8245
ER -